Fairfield Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-360
| Closed | -$145K | – | 204 |
|
|
2024
Q4 | $145K | Sell |
360
-5
| -1% | -$2.01K | 0.05% | 77 |
|
|
2024
Q3 | $170K | Sell |
365
-11
| -3% | -$5.12K | 0.06% | 79 |
|
|
2024
Q2 | $176K | Buy |
+376
| New | +$176K | 0.05% | 70 |
|
|
2023
Q4 | $144K | Hold |
355
| – | – | 0.06% | 87 |
|
|
2023
Q3 | $123K | Hold |
355
| – | – | 0.05% | 86 |
|
|
2023
Q2 | $125K | Hold |
355
| – | – | 0.05% | 85 |
|
|
2023
Q1 | $111K | Hold |
355
| – | – | 0.05% | 93 |
|
|
2022
Q4 | $103K | Hold |
355
| – | – | 0.05% | 91 |
|
|
2022
Q3 | $103K | Hold |
355
| – | – | 0.05% | 85 |
|
|
2022
Q2 | $100K | Sell |
355
-40
| -10% | -$11.3K | 0.05% | 82 |
|
|
2022
Q1 | $103K | Buy |
+395
| New | +$103K | 0.04% | 84 |
|